164 related articles for article (PubMed ID: 10809240)
1. Peritoneal kinetics and mesothelial markers in CCPD using icodextrin for daytime dwell for two years.
Posthuma N; Verbrugh HA; Donker AJ; van Dorp W; Dekker HA; Peers EM; Oe PL; ter Wee PM
Perit Dial Int; 2000; 20(2):174-80. PubMed ID: 10809240
[TBL] [Abstract][Full Text] [Related]
2. Serum disaccharides and osmolality in CCPD patients using icodextrin or glucose as daytime dwell.
Posthuma N; ter Wee PM; Donker AJ; Oe PL; van Dorp W; Peers EM; Verbrugh HA
Perit Dial Int; 1997; 17(6):602-7. PubMed ID: 9655161
[TBL] [Abstract][Full Text] [Related]
3. Assessment of the effectiveness, safety, and biocompatibility of icodextrin in automated peritoneal dialysis. The Dextrin in APD in Amsterdam (DIANA) Group.
Posthuma N; ter Wee PM; Donker AJ; Oe PL; Peers EM; Verbrugh HA
Perit Dial Int; 2000; 20 Suppl 2():S106-13. PubMed ID: 10911654
[TBL] [Abstract][Full Text] [Related]
4. Peritoneal defense using icodextrin or glucose for daytime dwell in CCPD patients.
Posthuma N; ter Wee P; Donker AJ; Dekker HA; Oe PL; Verbrugh HA
Perit Dial Int; 1999; 19(4):334-42. PubMed ID: 10507814
[TBL] [Abstract][Full Text] [Related]
5. Determination of high and low molecular weight molecules of icodextrin in plasma and dialysate, using gel filtration chromatography, in peritoneal dialysis patients.
García-López E; Anderstam B; Heimbürger O; Amici G; Werynski A; Lindholm B
Perit Dial Int; 2005; 25(2):181-91. PubMed ID: 15796147
[TBL] [Abstract][Full Text] [Related]
6. Icodextrin improves metabolic and fluid management in high and high-average transport diabetic patients.
Paniagua R; Ventura MD; Avila-Díaz M; Cisneros A; Vicenté-Martínez M; Furlong MD; García-González Z; Villanueva D; Orihuela O; Prado-Uribe MD; Alcántara G; Amato D
Perit Dial Int; 2009; 29(4):422-32. PubMed ID: 19602608
[TBL] [Abstract][Full Text] [Related]
7. Icodextrin metabolism and alpha-amylase activity in nonuremic rats undergoing chronic peritoneal dialysis.
García-López E; Pawlaczyk K; Anderstam B; Qureshi AR; Kuzlan-Pawlaczyk M; Heimbürger O; Werynski A; Lindholm B
Perit Dial Int; 2007; 27(4):415-23. PubMed ID: 17602150
[TBL] [Abstract][Full Text] [Related]
8. Peritoneal ultrafiltration and serum icodextrin concentration during dialysis with 7.5% icodextrin solution in Japanese patients.
Ota K; Akiba T; Nakao T; Nakayama M; Maeba T; Park MS; Tranaeus A; Yorioka N;
Perit Dial Int; 2003; 23(4):356-61. PubMed ID: 12968843
[TBL] [Abstract][Full Text] [Related]
9. The relationship between ultrafiltrate volume with icodextrin and peritoneal transport pattern according to the peritoneal equilibration test.
Araújo Teixeira MR; Pecoits-Filho RF; Romão Junior JE; Sabbaga E; Marcondes MM; Abensur H
Perit Dial Int; 2002; 22(2):229-33. PubMed ID: 11990408
[TBL] [Abstract][Full Text] [Related]
10. [Icodextrin improve angiogenesis of peritoneal membrane in continuous ambulatory peritoneal dialysis patients].
Dai HL; Lin AW; Qian JQ; Fang W; Ni ZH; Cao LO; Lin XH; Wu QW
Zhonghua Yi Xue Za Zhi; 2010 Nov; 90(40):2843-7. PubMed ID: 21162796
[TBL] [Abstract][Full Text] [Related]
11. Benefits of a continuous ambulatory peritoneal dialysis (CAPD) technique with one icodextrin-containing and two biocompatible glucose-containing dialysates for preservation of residual renal function and biocompatibility in incident CAPD patients.
Yoon HE; Chang YK; Shin SJ; Choi BS; Kim BS; Park CW; Song HC; Yoon SA; Jin DC; Kim YS
J Korean Med Sci; 2014 Sep; 29(9):1217-25. PubMed ID: 25246739
[TBL] [Abstract][Full Text] [Related]
12. [Peritoneal equilibrium test using icodextrin and glucose at different concentrations].
Guerrero A; Montes R; Martín-Herrera C; Ruiz A; Gallego T; Delgado-Pecellín C; Benítez M; Torán CD
Nefrologia; 2002; 22(4):340-7. PubMed ID: 12369125
[TBL] [Abstract][Full Text] [Related]
13. The kinetics of water transperitoneal transport during long-term peritoneal dialysis performed using icodextrin dialysis fluid.
Olszowska A; Zelichowski G; Waniewski J; Stachowska-Pietka J; Weryński A; Wańkowicz Z
Pol Arch Med Wewn; 2009 May; 119(5):305-10. PubMed ID: 19579812
[TBL] [Abstract][Full Text] [Related]
14. Icodextrin use in CCPD patients during peritonitis: ultrafiltration and serum disaccharide concentrations.
Posthuma N; ter Weel PM; Donker AJ; Peers EM; Oe PL; Verbrugh HA
Nephrol Dial Transplant; 1998 Sep; 13(9):2341-4. PubMed ID: 9761519
[TBL] [Abstract][Full Text] [Related]
15. Calcium and magnesium flux in automated peritoneal dialysis.
Eddington H; Hurst H; Ramli MT; Speake M; Hutchison AJ
Perit Dial Int; 2009; 29(5):536-41. PubMed ID: 19776047
[TBL] [Abstract][Full Text] [Related]
16. Icodextrin with nitroprusside increases ultrafiltration and peritoneal transport during long CAPD dwells.
Douma CE; Hiralall JK; de Waart DR; Struijk DG; Krediet RT
Kidney Int; 1998 Apr; 53(4):1014-21. PubMed ID: 9551412
[TBL] [Abstract][Full Text] [Related]
17. Icodextrin instead of glucose during the daytime dwell in CCPD increases ultrafiltration and 24-h dialysate creatinine clearance.
Posthuma N; ter Wee PM; Verbrugh HA; Oe PL; Peers E; Sayers J; Donker AJ
Nephrol Dial Transplant; 1997 Mar; 12(3):550-3. PubMed ID: 9075139
[TBL] [Abstract][Full Text] [Related]
18. Randomized controlled trial of icodextrin versus glucose containing peritoneal dialysis fluid.
Lin A; Qian J; Li X; Yu X; Liu W; Sun Y; Chen N; Mei C;
Clin J Am Soc Nephrol; 2009 Nov; 4(11):1799-804. PubMed ID: 19808224
[TBL] [Abstract][Full Text] [Related]
19. Correlation between peritoneal permeability and ultrafiltration volume with icodextrin-based peritoneal dialysis solution.
Moriishi M; Kawanishi H; Watanabe H; Tsuchiya S
Adv Perit Dial; 2004; 20():166-9. PubMed ID: 15384820
[TBL] [Abstract][Full Text] [Related]
20. Peritoneal transport characteristics with glucose polymer based dialysate.
Ho-dac-Pannekeet MM; Schouten N; Langendijk MJ; Hiralall JK; de Waart DR; Struijk DG; Krediet RT
Kidney Int; 1996 Sep; 50(3):979-86. PubMed ID: 8872974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
